Weight gain in patients with RET aberrant cancers treated with brain penetrant RET selective inhibitors

被引：3
|
作者：
Gouda, M. A. [1 ]
Hu, M. I. [2 ]
Cabanillas, M. E. [2 ]
Wu, J. [3 ,4 ]
Meric-Bernstam, F. [1 ]
Subbiah, V. [1 ,5 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX USA
[3] Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK USA
[4] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA
[5] Sarah Cannon Res Inst, Early Phase Drug Dev, Nashville, TN 37203 USA
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷 / 10期
基金：
美国国家卫生研究院;
关键词：
CACHEXIA; PATHWAY;
D O I：
10.1016/j.annonc.2023.07.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：946 / 948
页数：3
相关论文
共 50 条
  • [31] Targeting RET in patients with RET-rearranged lung cancers: Results from a global registry.
    Gautschi, Oliver
    Wolf, Juergen
    Milia, Julie
    Filleron, Thomas
    Carbone, David Paul
    Camidge, D. Ross
    Shih, Jin-Yuan
    Awad, Mark M.
    Cabillic, Florian
    Peled, Nir
    Van Den Heuvel, Michel
    Owen, Dwight Hall
    Kris, Mark G.
    Janne, Pasi A.
    Besse, Benjamin
    Cho, Byoung Chul
    Karp, Daniel D.
    Rosell, Rafael
    Mazieres, Julien
    Drilon, Alexander E.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [32] Selective RET inhibitors shift the treatment pattern of RET fusion-positive NSCLC and improve survival outcomes
    Chang Lu
    Xue-Wu Wei
    Yi-Chen Zhang
    Zhi-Hong Chen
    Chong-Rui Xu
    Ming-Ying Zheng
    Jin-Ji Yang
    Xu-Chao Zhang
    Qing Zhou
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 2987 - 2995
  • [33] Selective RET inhibitors shift the treatment pattern of RET fusion-positive NSCLC and improve survival outcomes
    Lu, Chang
    Wei, Xue-Wu
    Zhang, Yi-Chen
    Chen, Zhi-Hong
    Xu, Chong-Rui
    Zheng, Ming-Ying
    Yang, Jin-Ji
    Zhang, Xu-Chao
    Zhou, Qing
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 2987 - 2995
  • [34] RET inhibitors for patients with RET fusion-positive and RET wild-type non-small-cell lung cancer
    Rosell, Rafael
    Karachaliou, Niki
    LANCET ONCOLOGY, 2016, 17 (12): : 1623 - +
  • [35] Discovery and optimization of selective RET inhibitors via scaffold hopping
    Luo, Zhibo
    Wang, Lingli
    Fu, Zhifei
    Shuai, Bin
    Luo, Miaorong
    Hu, Guoping
    Chen, Jian
    Sun, Jikui
    Wang, Jiansong
    Li, Jian
    Chen, Shuhui
    Zhang, Yang
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 47
  • [36] Peritoneal effusion: an uncommon adverse effect of selective RET inhibitors
    Belli, C.
    Curigliano, G.
    ANNALS OF ONCOLOGY, 2020, 35 (05) : 478 - 480
  • [37] Non-Small-Cell Lung Cancers (NSCLCs) Harboring RET Gene Fusion, from Their Discovery to the Advent of New Selective Potent RET Inhibitors: "Shadows and Fogs"
    Spitaleri, Gianluca
    Aliaga, Pamela Trillo
    Attili, Ilaria
    Del Signore, Ester
    Corvaja, Carla
    Pellizzari, Gloria
    Katrini, Jalissa
    Passaro, Antonio
    de Marinis, Filippo
    CANCERS, 2024, 16 (16)
  • [38] Efficacy and Safety of Selective RET Inhibitors in Patients with Advanced Hereditary Medullary Thyroid Carcinoma
    Hamidi, Sarah
    Yedururi, Sireesha
    Hu, Mimi I.
    Busaidy, Naifa L.
    Sherman, Steven I.
    Jimenez, Camilo
    Grubbs, Elizabeth G.
    Maniakas, Anastasios
    Zafereo, Mark E.
    Subbiah, Vivek
    Waguespack, Steven G.
    THYROID, 2025, 35 (01) : 6 - 17
  • [39] Clinical features of progression and outcomes with subsequent therapies in patients treated with RET-inhibitors
    Marinello, Arianna
    Zrafi, Wael Salem
    Massa, Giacomo
    Tabbo, Fabrizio
    Citarella, Fabrizio
    Dall'Olio, Filippo Gustavo
    Colin, Lindsay
    Bria, Emilio
    Metro, Giulio
    Minatta, Jose Nicolas
    Calles, Antonio
    Monnet, Isabelle
    Tagliamento, Marco
    De Saint Basile, Hortense Gaultier
    Girard, Nicolas
    Pagliaro, Arianna
    Cortinovis, Diego Luigi
    Raimbourg, Judith
    Zanchetta, Carol
    Mountzios, Giannis
    Nana, Frank Aboubakar
    Terrisse, Safae
    Russo, Alessandro
    Iranzo, Patricia
    Audigier-Valette, Clarisse
    Rochigneux, Philippe
    Fallet, Vincent
    Duruisseaux, Michael
    Cousin, Sophie
    Guisier, Florian
    Mezquita, Laura
    Remon, Jordi
    Gazzah, Anas
    Planchard, David
    Besse, Benjamin
    Aldea, Mihaela
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [40] Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET-Rearranged Lung Cancers
    Drilon, Alexander
    Lin, Jessica J.
    Filleron, Thomas
    Ni, Ai
    Milia, Julie
    Bergagnini, Isabella
    Hatzoglou, Vaios
    Velcheti, Vamsidhar
    Offin, Michael
    Li, Bob
    Carbone, David P.
    Besse, Benjamin
    Mok, Tony
    Awad, Mark M.
    Wolf, Jurgen
    Owen, Dwight
    Camidge, D. Ross
    Riely, Gregory J.
    Peled, Nir
    Kris, Mark G.
    Mazieres, Julien
    Gainor, Justin F.
    Gautschi, Oliver
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : 1595 - 1601
12345